Back
Virtus AllianzGI Diversified Income & Convertible Fund Vs. Ascendis Pharma AS Industry Stock Comparison
Buy
59
ACV
Virtus AllianzGI Diversified Income & Convertible Fund
Last Price:
$21.86
Seasonality Move:
6.01%
Sell
30
ASND
Ascendis Pharma AS
Last Price:
$157.88
Seasonality Move:
2.56%
Buy
59
Virtus AllianzGI Diversified Income & Convertible Fund (ACV)
is a Buy
Is Virtus AllianzGI Diversified Income & Convertible Fund a Buy, Sell or Hold?
-
The current Virtus AllianzGI Diversified Income & Convertible Fund [ACV] share price is $21.83. The Score for ACV is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
ACV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
-
The current Ascendis Pharma AS [ASND] share price is $157.27. The Score for ASND is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
ASND is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACV Stock Price Chart
What is Virtus AllianzGI Diversified Income & Convertible Fund's stock price today?
-
The Virtus AllianzGI Diversified Income & Convertible Fund share price today is $21.83Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACV is experiencing slight buying pressure.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $157.27The current trend is moderately bearish and ASND is experiencing selling pressure, which indicates risk of future bearish movement.
ACV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.48 | Buy |
Relative Strength Index (14 RSI): | 67.82 | Buy |
Chaikin Money Flow: | 1666 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.1 - 21.72) | Buy |
Bollinger Bands (100): | (19.81 - 22.53) | Buy |
ASND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.3 | Buy |
Relative Strength Index (14 RSI): | 47.63 | Sell |
Chaikin Money Flow: | -321631 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (156.47 - 166.41) | Sell |
Bollinger Bands (100): | (134.11 - 162.49) | Buy |
ACV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.75 | Buy |
20-day SMA: | 21.2 | Buy |
50-day SMA: | 20.22 | Buy |
200-day SMA: | 21.37 | Buy |
8-day EMA: | 21.65 | Buy |
20-day EMA: | 21.21 | Buy |
50-day EMA: | 20.81 | Buy |
200-day EMA: | 21.19 | Buy |
ASND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 159.31 | Sell |
20-day SMA: | 161.47 | Sell |
50-day SMA: | 158.41 | Sell |
200-day SMA: | 140.47 | Buy |
8-day EMA: | 159.4 | Sell |
20-day EMA: | 159.59 | Sell |
50-day EMA: | 156.7 | Buy |
200-day EMA: | 143.85 | Buy |
Virtus AllianzGI Diversified Income & Convertible Fund Earnings Growth & ACV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.59 per share, an increase this year of $2.02 per share, and an increase next year of $7.29 per share.
Virtus AllianzGI Diversified Income & Convertible Fund Technical Analysis
May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ascendis Pharma AS Technical Analysis
May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |